Consensus Transgene

Stocks

TNG

FR0005175080

Biotechnology & Medical Research

Real-time Euronext Paris 08:00:24 06/10/2026 BST			5-day change	1st Jan Change
0.7230 ^EUR	-0.69%		-0.82%	-24.69%

09-25	Transgene provides update on its operations
09-08	Transgene Expands ProBioGen Partnership With Additional License	MT

Evolution of the Average Target: Transgene

Evolution of the Target Price: Transgene

Changes in Analyst Recommendations: Transgene

b324b6af733.igdlOWmn1JY6JvqsHZqg32GHibsw2NL-ZDjTqFifkL4.sk0zcl2VgtxXfLboXPzhrgbq7ItItqe6EQmg6QLY_Nn_WAJBNsC47ngLlQ~ee727608ab0248eeca689befce5b943b

Analysts' recommendations: Transgene

06-25	Oddo BHF Stays Positive on Transgene
04-07	Transgene stands out following licensing agreement with NEC Bio
11-27	Oddo BHF Lowers Target Price on Transgene but Remains Upbeat
13/10/25	Transgene and BioInvent International AB Jointly Present a Poster on Transational Data and Updated Clinical Results from the Phase I Study of BT-001	CI
18/09/25	Transgene: analysts reiterate their recommendations after results
17/09/25	The day the Fed resumed its rate cuts
06/11/24	Transgene: Invest Securities remains Buy
15/10/24	Transgene: Invest Securities confirms its Buy recommendation
26/09/24	Transgene: Invest Securities confirms its opinion
06/06/23	Transgene: Invest Securities confirms its Buy rating
05/06/23	Transgene: Invest Securities reiterates its recommendation
22/03/23	Transgene: Invest Securities reduces its target
10/01/23	Transgene: Invest Securities confirms its Buy rating

More recommendations

Bio Therapeutic Drugs

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	TRANSGENE			-	-	+51.1%
	WUXI APPTEC CO., LTD.					+11.79%
	ARGENX SE					+28.45%
	LONZA GROUP AG					+19.72%
	REVOLUTION MEDICINES, INC.					+24.61%
	IQVIA HOLDINGS INC.					+8.81%
	BEONE MEDICINES AG					+19.87%
	CELLTRION, INC.					+46.63%
	WUXI BIOLOGICS (CAYMAN) INC.					+5.13%
	BIONTECH SE					+19.99%
	Average					+23.61%
	Weighted average by Cap.					+19.93%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

0.7280EUR

Average target price

1.100EUR

Spread / Average Target

+51.10%

High Price Target

1.100EUR

Spread / Highest target

+51.10%

Low Price Target

1.100EUR

Spread / Lowest Target

+51.10%

Analyst Consensus Detail

Consensus revision (last 18 months)

Stock Market
Stocks
TNG Stock
Consensus Transgene

As early as today, start finding the best investment opportunities!